ArticleJAMA network open2021

Evaluation of the Cost-effectiveness of Doublet Therapy in Metastatic BRAF Variant Colorectal Cancer.

Kishan K Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.